RESEARCH ACTIVITY
Develop a dynamic that allows studies in the area of thoracic tumors to be carried out at the initiative of GECP members.
Support and participate in initiatives of other groups, societies or entities for the elaboration of transversal and multidisciplinary studies in the area of thoracic tumors
Create a Scientific Award and a Grant, in the areas of academic formation, research and / or acquisition of new techniques.
SCIENTIFIC ACTIVITY
Complete and spread, either in publication or on the websites, the national guidelines for diagnostic and treatment of chest tumors.
Streamline the Journal of the Lung Cancer Study Group, evolving into a more comprehensive format that reflects the Portuguese reality, and open to all who want to participate in it.
SOCIAL AWARENESS ACTIVITY
Improve and streamline the GECP website in real time and with greater interactivity.
Establish partnerships with patient Associations
Carry out lung cancer dissemination activities in the context of prevention, combating risk factors, and alert to signs and symptoms of thoracic oncological disease and its relationship with smoking.
GECP JOURNAL
CONGRESSES
PHOTO GALLERY
PUBLICATIONS
The GECP launches a Lung Cancer Guide for patients and caregivers, with everything you should know about the disease and the treatments currently available. The more informed you are, the better you will be able to ask the right questions and participate in decisions regarding your treatment plan.
EVENTS
AUTUMN MEETING
24 de outubro
NEWS
22 de October, 2020
I have lung cancer. Should I be vaccinated against the flu? – GECP and PULMONALE join to answer all your questions questions
At the beginning of each vaccination season, lung cancer patients frequently have doubts about whether it is beneficial and safe to get the flu vaccine. This year, the COVID-19 pandemic has brought even more uncertainties on this topic. For this... read more...9 de October, 2020
TERAVOLT reveal that patients with malignant thoracic tumors have a high risk of mortality from COVID 19
The Thoracic Cancers International COVID 19 Collaboration, also known as TERAVOLT, is an international consortium that was created to understand the impact of COVID-19 on patients with thoracic malignancies. Made up of medical experts from leading institutions around the world,... read more...1 de October, 2020
